During the past decade, Arkansas Diagnostic Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arkansas Diagnostic Center" #1 sponsor was "CymaBay Therapeutics, Inc." with 1 trials, followed by "Enanta Pharmaceuticals, Inc" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Inventiva Pharma" with 1 trials sponsored and "Sagimet Biosciences Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arkansas Diagnostic Center" #1 collaborator was "Novo Nordisk A/S" with 1 trials as a collaborator, "Pharmaceutical Research Associates" with 1 trials as a collaborator and "Triangle Biostatistics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Arkansas Diagnostic Center" are "Nonalcoholic Steatohepatitis" (2 trials), "Primary Biliary Cholangitis" (2 trials), "NASH - Nonalcoholic Steatohepatitis" (1 trials) and "Nonalcoholic Fatty Liver Disease" (1 trials). Many other conditions were trialed in "Arkansas Diagnostic Center" in a lesser frequency.

Most popular intervention types in "Arkansas Diagnostic Center" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Cenicriviroc" (1 trials), "Cilofexor (CILO)/Firsocostat (FIR)" (1 trials), "EDP-305 1 mg" (1 trials) and "EDP-305 2.5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arkansas Diagnostic Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Arkansas Diagnostic Center". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Arkansas Diagnostic Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Arkansas Diagnostic Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".